The country appears to be cracking down on people linked to the acquisition of Manus, a Singapore company with Chinese roots, ...

Researchers examined 54 clinical trials to see if cannabis helps treat mental health or addiction issues. They found minimal proof of benefit, alongside a higher risk of mild side effects like ...

Meta Platforms, Inc. stock is down 15% since Jan. 29—a potential buying opportunity. Learn why META's AI monetization and DAU ...

Meta adds stronger anti-impersonation tools on Facebook while rewarding original creators and pushing copycats and reposted ...

Glucagon-like peptide-1 receptor agonist therapy for type 2 diabetes or weight management is associated with a lower risk of ...

It seems critical thinking is often misinterpreted as thinking that applies critique/criticism—and, coincidentally, this is a ...

Psychosocial interventions offered limited benefits for reducing symptoms and substance use in patients with schizophrenia ...

A landmark Lancet Psychiatry paper published today has found no evidence that medicinal cannabis is effective in treating anxiety, depression or post-traumatic stress disorder (PTSD).

The Personal Data Protection Ordinance (PDPO) 2025 marks a turning point in Bangladesh’s digital governance, exposing how Meta’s push to lower the child-age threshold pits corporate profit against chi ...

Introduction With the rapid ageing of the global population, the number of persons with dementia (PwDs) is increasing, placing substantial psychological and physical burdens on family caregivers.

Meta plans to significantly increase its AI spending this year. What does that mean for investors? Should they be worried?